ArticleAnnals of thoracic surgery short reports2025
Valve-Sparing Aortic Root Replacement in Congenital Aortopathy: Long-term Results.
Article in Annals of thoracic surgery short reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The objective of this study was to evaluate long-term outcomes for valve-sparing root replacement (VSRR) in patients with congenital aortopathy. Methods: In 107 patients undergoing VSRR in an elective setting with preoperative data from 1998 to 2022, information about operative strategy and postoperative course was collected. Patients were assigned to the congenital aortopathy group if a genetic mutation was confirmed or if a bicuspid aortic valve was present and compared with patients with tricuspid aortic valve. Long-term follow-up was obtained through outpatient visits or by telephone interviews. Results: Fifty-two percent (n = 56) were congenital aortopathy patients. Patients without congenital aortopathy were older ( Conclusions: VSRR in congenital aortopathy patients has good long-term results. During follow-up, the rate of thromboembolic events might have an impact on optimal medical therapy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.